Cargando…

Dual Viscosity Mixture Vehicle for Intratympanic Dexamethasone Delivery Can Block Ototoxic Hearing Loss

Clinically there is no effective method to prevent drug induced hearing loss in patients undergoing chemotherapy and anti-tuberculosis therapy. In this study, we developed an intratympanic (IT) local drug delivery vehicle featuring hyaluronic acid-based dual viscosity mixture encapsulation of dexame...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui, Suh, Myung-Whan, Oh, Seung Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581269/ https://www.ncbi.nlm.nih.gov/pubmed/34776942 http://dx.doi.org/10.3389/fphar.2021.701002

Ejemplares similares

Dual viscosity mixture vehicle for intratympanic steroid treatment modifies the ROS and inflammation related proteomes
por: Jung, Jin Woo, et al.
Publicado: (2023)

Intratympanic Administration of Dieckol Prevents Ototoxic Hearing Loss
por: Li, Hui, et al.
Publicado: (2022)

Intratympanic Dexamethasone Role in Hearing Protection in Cancer Patients
por: Gupta, Dipti, et al.
Publicado: (2023)

Intratympanic dexamethasone for managing pregnant women with sudden hearing loss
por: Fu, Yaoyao, et al.
Publicado: (2018)

Intratympanic dexamethasone injection for sudden sensorineural hearing loss in pregnancy
por: Lyu, Yan-Lu, et al.
Publicado: (2020)

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
por: Memari, Faramarz, et al.
Publicado: (2014)

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss
por: Jung, So-Young, et al.
Publicado: (2021)

The ototoxic effect of intratympanic terbinafine applied in the middle ear of rats
por: Sagit, Mustafa, et al.
Publicado: (2013)

Correction: Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
Publicado: (2014)

Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss
por: Yoshida, Tadao, et al.
Publicado: (2012)

Systemic effects of intratympanic dexamethasone therapy
por: Novoa, Eva, et al.
Publicado: (2014)

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone
por: Le, Thi Phuc, et al.
Publicado: (2023)

Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
por: Berjis, Nezamoddin, et al.
Publicado: (2016)

Idiopathic sudden sensorineural hearing loss: Effectiveness of salvage treatment with low-dose intratympanic dexamethasone
por: Salvador, Pedro, et al.
Publicado: (2021)

The Effect of Intratympanic Dexamethasone with Oral Prednisolone as a Primary Treatment in Idiopathic Sudden Sensorineural Hearing Loss
por: Khorsandi Ashtiani, Mohammad Taghi, et al.
Publicado: (2012)

The Effect of Intracochlear and Intratympanic Dexamethasone on Cochlear Implant Impedance
por: Ardıç, Fazıl Necdet, et al.
Publicado: (2023)

Intratympanic corticosteroids for sudden sensorineural hearing loss
por: Plontke, Stefan K, et al.
Publicado: (2022)

Anti-apoptotic effect of dexamethasone in an ototoxicity model
por: Lee, Jin Ho, et al.
Publicado: (2017)

Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma
por: Cho, Jung-Ah, et al.
Publicado: (2021)

Clinical Analysis of Intratympanic Injection of Dexamethasone for Treating Sudden Deafness
por: Li, Xin, et al.
Publicado: (2021)

In Vivo Imaging of Click-Crosslinked Hydrogel Depots Following Intratympanic Injection
por: Ju, Hyeon Jin, et al.
Publicado: (2020)

Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis
por: Chung, Juyong, et al.
Publicado: (2022)

Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)

Current Strategies to Combat Cisplatin-Induced Ototoxicity
por: Yu, Dehong, et al.
Publicado: (2020)

Idiopathic sudden sensorineural hearing loss: effectiveness of salvage treatment with intratympanic dexamethasone or hyperbaric oxygen therapy in addition to systemic steroids
por: Mariani, Cinzia, et al.
Publicado: (2023)

Prediction of hearing recovery in sudden deafness treated with intratympanic steroids
por: ATTANASIO, G., et al.
Publicado: (2018)

Intratympanic Methylprednisolone as Rescue Therapy in Sudden Sensorineural Hearing Loss
por: Raymundo, Igor Teixeira, et al.
Publicado: (2015)

Intratympanic corticosteroid for sudden hearing loss: does it really work?()()
por: Barreto, Monique Antunes de Souza Chelminski, et al.
Publicado: (2015)

Protection of Hearing Loss in Ototoxic Mouse Model Through SPIONs and Dexamethasone-Loaded PLGA Nanoparticle Delivery by Magnetic Attraction
por: Park, Jeong-Eun, et al.
Publicado: (2022)

Comparison of the Effects of Intratympanic Steroid Injection at Different Intervals in Sudden Sensorineural Hearing Loss
por: Sung, Han Kyung, et al.
Publicado: (2020)

Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss
por: Hara, Jared H., et al.
Publicado: (2018)

Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss
por: Amizadeh, Maryam, et al.
Publicado: (2021)

Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss
por: Zhai, Tianying, et al.
Publicado: (2023)

Association Between the Number of Intratympanic Steroid Injections and Hearing Recovery in Sudden Sensorineural Hearing Loss
por: Wang, Yixu, et al.
Publicado: (2021)

Contralateral spreading of substances following intratympanic nanoparticle-conjugated gentamicin injection in a rat model
por: Lee, Sang-Yeon, et al.
Publicado: (2020)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019)

Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant cases
por: Ismaiel, Wael F., et al.
Publicado: (2022)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

Intratympanic Steroids in Severe to Profound Sudden Sensorineural Hearing Loss as Salvage Treatment
por: Lee, Jong Dae, et al.
Publicado: (2010)

Is Intratympanic Dexamathasone Injection Effective for the Treatment of Idiopathic Sudden Sensorineural Hearing Loss?
por: Lee, Kyu Ho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oasnnckd1fv4e0oclmckdrk7i8